HPGC Renmintongtai Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
HPGC Renmintongtai Pharmaceutical has a total shareholder equity of CN¥2.8B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 39.3%. Its total assets and total liabilities are CN¥7.4B and CN¥4.5B respectively. HPGC Renmintongtai Pharmaceutical's EBIT is CN¥414.6M making its interest coverage ratio 54.7. It has cash and short-term investments of CN¥1.1B.
Key information
39.3%
Debt to equity ratio
CN¥1.11b
Debt
Interest coverage ratio | 54.7x |
Cash | CN¥1.05b |
Equity | CN¥2.83b |
Total liabilities | CN¥4.52b |
Total assets | CN¥7.35b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 600829's short term assets (CN¥6.9B) exceed its short term liabilities (CN¥4.4B).
Long Term Liabilities: 600829's short term assets (CN¥6.9B) exceed its long term liabilities (CN¥141.3M).
Debt to Equity History and Analysis
Debt Level: 600829's net debt to equity ratio (2%) is considered satisfactory.
Reducing Debt: 600829's debt to equity ratio has increased from 19.6% to 39.3% over the past 5 years.
Debt Coverage: 600829's debt is not well covered by operating cash flow (3.2%).
Interest Coverage: 600829's interest payments on its debt are well covered by EBIT (54.7x coverage).